EXCELLENCE IN SAFETY & EFFICACY:
BIODEGRADABLE POLYMER &
COBALT-CHROMIUM PLATFORM
SIROLIMUS ELUTING COCR CORONARY STENT SYSTEM
SEQUENCE FLEX™
The combination of Sirolimus antiproliferative action combined with biodegradable polymer and a proven balloon catheter sets new standards in treatment of clinically complex lesions.
Carrier coating and drug are absorbed simultaneously within three months, which covers exactly the time where restenosis tend to occur most frequently.
Sirolimus is associated with minimal neointimia hyperplasia & Sirolimus eluting stents produce a significant lower incidence of major adverse cardiac events (MACE).
Sirolimus (Rapamycin) eluting
Reliable and even drug release
Proven cobalt-chromium stent platform
Excellent flexibility through 3-interlink stent design
PLGA polymer - uniform, localized drug delivery
Assures biocompatibility, no auxiliary polymer used
Optimal hydrophilic coating for maximized crossability
Drug loading: 1.4 µg/mm2
Prevents development of stent thrombosis and MACE
Coating degrade 100% int carbon dioxide and water
Quick arterial wall healing, restores vessel physiology
Inhibits neointimal formation and promotes endothelialization
Large cell openting gives comfort to access side brances and cross with multiple devices
TECHNICAL SPECIFICATIONS

DELIVERY SYSTEM SPECIFICATIONS

PRODUCT ORDERING INFORMATION
